Consolidated Balance Sheets, as of December 31 - USD ($) $ in Millions		Dec. 31, 2019	Dec. 31, 2018
ASSETS
Cash and cash equivalents		$ 1,291	$ 1,100
Trade receivables (net of allowances of $35 at December 31, 2019 and $40 at December 31, 2018)		2,212	2,262
Other receivables (net of allowances of $44 at December 31, 2019 and $47 at December 31, 2018)		715	744
Inventories, net		2,546	2,592
Other current assets		866	906
Total current assets		7,630	7,604
Property, plant and equipment and right of use assets, net		8,733
Property, plant and equipment, net			8,482
Operating lease right of use assets		568	0
Goodwill		20,848	20,725
Intangible assets, net		17,957	18,002
Prepaid pension assets		516	132
Deferred income taxes		726	255
Equity method investments	[1]	7,212	7,123
Other assets		359	406
TOTAL ASSETS		64,549	62,729
LIABILITIES
Short-term borrowings		2,638	3,192
Current portion of long-term debt		1,581	2,648
Accounts payable		5,853	5,794
Accrued marketing		1,836	1,756
Accrued employment costs		769	701
Other current liabilities		2,645	2,646
Total current liabilities		15,322	16,737
Long-term debt		14,207	12,532
Long-term operating lease liabilities		403	0
Deferred income taxes		3,338	3,552
Accrued pension costs		1,190	1,221
Accrued postretirement health care costs		387	351
Other liabilities		2,351	2,623
TOTAL LIABILITIES		37,198	37,016
Commitments and Contingencies
EQUITY
Common Stock, no par value (5,000,000,000 shares authorized and 1,996,537,778 shares issued at December 31, 2019 and December 31, 2018)		0	0
Additional paid-in capital		32,019	31,961
Retained earnings		26,653	24,491
Accumulated other comprehensive losses		(10,258)	(10,630)
Treasury stock, at cost (561,531,524 shares at December 31, 2019 and 545,537,923 shares at December 31, 2018)		(21,139)	(20,185)
Total Mondelēz International Shareholders’ Equity		27,275	25,637
Noncontrolling interest		76	76
TOTAL EQUITY		27,351	25,713
TOTAL LIABILITIES AND EQUITY		$ 64,549	$ 62,729

[1] Includes a basis difference of approximately $330 million as of December 31, 2019 and $340 million as of December 31, 2018 between the U.S. GAAP accounting basis for our equity method investments and the U.S. GAAP accounting basis of our investees’ equity.